Alhemo’s expanded approval drew on explorer8, a Phase 3 study that enrolled about 150 hemophilia A or B patients, who didn't ...

The Rare Rewritten campaign hopes to change a misconception about women with X-linked disorders, columnist G Shellye Horowitz ...

Columnist Jennifer Lynne shares what it's like to be a woman living with hemophilia — things she wishes doctors would know about the disorder.

Columnist Allyx Formalejo says that due to ADHD, her tendency to be hyperfocused and need to "help" is really a need for ...

With the launch of a U.S. trial, a treatment using the B-cell medicine BE-101 has been given to a hemophilia B patient for ...

Marisa Wexler is a senior science writer for Hemophilia News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of hemophilia topics.

Columnist Joe MacDonald says his son Caeleb learned from living with hemophilia how important it is to always have a plan B.

Learning to adapt to constant numbness and tingling in her hands has given columnist Cazandra Campos-MacDonald new insight into her sons.

Hemophilia treatment can increase life expectancy. Treatment options include factor replacement therapies, bypassing agents, gene therapy.

Columnist G Shellye Horowitz shares the many miracles she's experienced in her life despite living with the bleeding disorder ...

CHMP has advised that Alhemo be approved for people with severe hemophilia A and moderate or severe hemophilia B without ...